Skip to main content
. 2015 Aug 21;6(30):29388–29395. doi: 10.18632/oncotarget.5001

Figure 1. Receiver operating characteristics (ROC) analysis of ΔSUVpeak for the prediction of pathologic complete response (pCR).

Figure 1

ROC analysis for prediction of overall pCR with the primary lesions’ ΔSUVpeak in HER2-positive breast cancer A. and HER2-negative breast cancer B. ROC analysis for prediction of axillary lymph node (ALN) pCR with ΔSUVpeaks of ALN metastases in HER2-positive breast cancer C. and HER2-negative breast cancer D. ΔSUVpeak refers to the difference in standard uptake values between baseline and after two chemotherapy cycles.